Fosun Pharma (02196) announced that in July 2024, under the repurchase plan, the company repurchased 0.482 million shares of A-shares through centralized bidding trading (accounting for approximately 0.0180% of the total share capital of the company as of July 31, 2024, i.e. 2.672 billion shares, the same below), with a total repurchase amount of approximately RMB 10.6336 million (excluding transaction fees), and the highest price is RMB 22.13/share and the lowest price is RMB 22.03/share.
As of July 31, 2024, under the repurchase plan, the company repurchased a total of 1.9398 million shares of A-shares through centralized bidding trading (accounting for approximately 0.0726% of the total share capital of the company as of July 31, 2024), with a total repurchase amount of approximately RMB 42.9575 million (excluding transaction fees), and the highest price is RMB 22.32/share and the lowest price is RMB 22.03/share.
